As of the latest Form 4 filed Jul 10, 2026.
What Biocardia Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
2 different Biocardia Inc insiders made open-market purchases in the last 30 days. When several insiders buy at once it’s a stronger, harder-to-explain-away signal than a single trade — how to read this.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 24 most recent filings for BCDA.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | 2026-07-10 | Altman Peter President and CEO | PPurchase | +1.00K | $0.94 | $940.00 | No | Form 4 ↗ |
| 2026-07-10 | 2026-07-09 | Altman Peter, President and CEO | PPurchase | +1.00K | $0.90 | $900.00 | No | Form 4 ↗ |
| 2026-07-10 | 2026-07-08 | Altman Peter, President and CEO | PPurchase | +5.50K | $0.97 | $5.33K | No | Form 4 ↗ |
| 2026-07-08 | 2026-07-08 | Altman Peter President and CEO | PPurchase | +5.40K | $0.96 | $5.21K | No | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | Altman Peter President and CEO | FTax | −54.6K | $1.24 | $67.7K | No | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | McClung David Chief Financial Officer | FTax | −23.1K | $1.24 | $28.7K | No | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | GILLIS EDWARD M Senior Vice President, Devices | FTax | −17.3K | $1.24 | $21.4K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-29 | Altman Peter President and CEO | AAward | +111K | $1.20 | $133K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-29 | McClung David Chief Financial Officer | AAward | +60.5K | $1.20 | $72.6K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-29 | GILLIS EDWARD M Senior Vice President, Devices | AAward | +39.5K | $1.20 | $47.4K | No | Form 4 ↗ |
| 2026-06-24 | 2026-06-23 | STERTZER SIMON H Director | PPurchase | +39.0K | $1.00 | $39.0K | No | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | STERTZER SIMON H, Director | PPurchase | +70.2K | $0.92 | $64.6K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | Altman Peter President and CEO | PPurchase | +800.00 | $0.96 | $768.00 | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-17 | Altman Peter, President and CEO | PPurchase | +1.50K | $0.85 | $1.27K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-09 | Altman Peter President and CEO | PPurchase | +5.00K | $0.85 | $4.25K | No | Form 4 ↗ |
| 2026-05-21 | 2026-05-20 | Altman Peter President and CEO | PPurchase | +1.50K | $0.92 | $1.38K | No | Form 4 ↗ |
| 2026-05-21 | 2026-05-19 | Altman Peter, President and CEO | PPurchase | +200.00 | $0.95 | $190.00 | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-18 | Altman Peter President and CEO | PPurchase | +5.70K | $0.92 | $5.24K | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-15 | Altman Peter President and CEO | PPurchase | +5.10K | $1.02 | $5.20K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-29 | Altman Peter President and CEO | PPurchase | +5.00K | $1.11 | $5.55K | No | Form 4 ↗ |
| 2026-04-22 | 2026-04-21 | Altman Peter President and CEO | PPurchase | +400.00 | $1.23 | $492.00 | No | Form 4 ↗ |
| 2026-04-22 | 2026-04-20 | Altman Peter, President and CEO | PPurchase | +600.00 | $1.23 | $738.00 | No | Form 4 ↗ |
| 2026-03-26 | 2026-03-25 | Altman Peter President and CEO | PPurchase | +300.00 | $1.22 | $366.00 | No | Form 4 ↗ |
| 2026-03-26 | 2026-03-24 | Altman Peter, President and CEO | PPurchase | +600.00 | $1.24 | $744.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also BCDA’s full analysis or the market-wide insider trading feed. The tabs above jump to BCDA’s other SEC data.
Source: SEC Form 4 filings for BCDA, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.